Gennex Laboratories Limited

Equities

GENNEX6

INE509C01026

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:54 2024-05-06 am EDT 5-day change 1st Jan Change
14.98 INR -4.59% Intraday chart for Gennex Laboratories Limited -6.84% -10.89%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Gennex Laboratories Limited Appoints Dr. S. Ch. Dharma Rao as Additional Director (Non- Executive - Non Independent Director) CI
Gennex Laboratories Limited Announces Resignation of Tiruvarur Muralidharan Gopalakrishnan as Whole Time Director CI
Gennex Laboratories Gets Good Manufacturing Practices Certificate from Indian Regulator MT
Gennex Laboratories Limited announced that it expects to receive INR 966.125 million in funding from Premier Fiscal Services Pvt Ltd CI
Gennex Laboratories Board to Consider Raising Funds Via Equity MT
Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Gennex Laboratories Gets Permission to Manufacture, Sell Fexofenadine, Minoxidil MT
Gennex Laboratories Limited Obtains Approval of Additional Products from Drug Control Administration, Government of Telangana CI
Gennex Laboratories Gets WHO-GMP Certification from Drug Control Administration, Government of Telangana MT
Gennex Laboratories Arm Gets Drug Manufacturing License MT
Gennex Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Gennex Laboratories Limited Appoints Dinesh Kumar Kejriwal as Company Secretary & Compliance Officer CI
Gennex Laboratories Limited completed the acquisition of 6.73% minority stake in Deccan Remedies Limited. CI
Gennex Laboratories Limited Approves the Acceptance of Resignation of Rajesh Vankadara as Company Secretary & Compliance Officer CI
Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Gennex Laboratories Limited Announces Rajesh Vankadara to Resign as Company Secretary & Compliance Officer Effect from February 26, 2023 CI
Gennex Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Gennex Laboratories Limited Receives New 2 Licenses to Manufacture Drugs for Purposes of Examination, Test or Analysis from the Drug Control Administration , Government of Telangana CI
Gennex Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Gennex Laboratories Board OKs Up to $5.3 Million Rights Issue MT
Gennex Laboratories Board to Consider Fundraising Via Debt or Equity Offering MT
Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Gennex Laboratories Limited agreed to acquire additional 6.73% minority stake in Deccan Remedies Limited. CI
Chart Gennex Laboratories Limited
More charts
Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing bulk drugs, intermediaries, and biotech products. The Company has a robust product portfolio spread over major product segments encompassing expectorants, muscle relaxants, analgesic and anti-fungal. The Company operates through the Pharmaceutical Products (Bulk Drugs) segment. The Company's products include active pharmaceutical ingredients, such as Guaifenesin USP/BP/EP/IP, which is an expectorant, (mucolyte); Methocarbamol USP, which is a relaxant (skeletal muscle relaxant); Phenazopyridine Hcl USP, which is an urinary tract analgesic; Fluconazole EP/USP, which is an anti-fungal product; Mephenesin IP/BP, which is a muscle relaxant; Chlorphenesin IP/BP, which is anti-fungal, and Melitracen Hcl, which is an antidepressant. The Company has manufacturing facilities in India which cater to both domestic and international markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. GENNEX6 Stock
  4. News Gennex Laboratories Limited
  5. Gennex Laboratories Gets WHO-GMP Certification from Drug Control Administration, Government of Telangana
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW